MOVIANTO -DENNIS SPAMER, new Board Member of Movianto GERMANY
The Walden Group is pleased to announce the appointment of Dennis Spamer (38) as member of the Board authorized to
Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA
Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin
Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour
I Holland to Deliver a Free Tooling Maintenance Webinar Series
Ensuring punches and dies are kept in optimum condition is essential to produce high quality tablets. As the demand for
Two Immigrants, One Unique Plan For A Biopharma
The American Dream is why the United States is considered the “land of opportunity,” and why for centuries immigrants have
Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs
Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight